Balza E - Search Results

1

Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants.

Mariani G, Lasku A, Balza E, Gaggero B, Motta C, Di Luca L, Dorcaratto A, Viale GA, Neri D, Zardi L. Mariani G, et al. Among authors: balza e. Cancer. 1997 Dec 15;80(12 Suppl):2378-84. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2378::aid-cncr7>3.3.co;2-0. Cancer. 1997. PMID: 9406686

2

Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.

Borsi L, Balza E, Bestagno M, Castellani P, Carnemolla B, Biro A, Leprini A, Sepulveda J, Burrone O, Neri D, Zardi L. Borsi L, et al. Among authors: balza e. Int J Cancer. 2002 Nov 1;102(1):75-85. doi: 10.1002/ijc.10662. Int J Cancer. 2002. PMID: 12353237

3

Lack of specificity of endoglin expression for tumor blood vessels.

Balza E, Castellani P, Zijlstra A, Neri D, Zardi L, Siri A. Balza E, et al. Int J Cancer. 2001 Nov;94(4):579-85. doi: 10.1002/ijc.1505. Int J Cancer. 2001. PMID: 11745447

4

Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.

Borsi L, Balza E, Allemanni G, Zardi L. Borsi L, et al. Among authors: balza e. Exp Cell Res. 1992 Mar;199(1):98-105. doi: 10.1016/0014-4827(92)90466-l. Exp Cell Res. 1992. PMID: 1310473

5

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.

Carnemolla B, Borsi L, Balza E, Castellani P, Meazza R, Berndt A, Ferrini S, Kosmehl H, Neri D, Zardi L. Carnemolla B, et al. Among authors: balza e. Blood. 2002 Mar 1;99(5):1659-65. doi: 10.1182/blood.v99.5.1659. Blood. 2002. PMID: 11861281 Free article.

6

Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.

Balza E, Mortara L, Sassi F, Monteghirfo S, Carnemolla B, Castellani P, Neri D, Accolla RS, Zardi L, Borsi L. Balza E, et al. Clin Cancer Res. 2006 Apr 15;12(8):2575-82. doi: 10.1158/1078-0432.CCR-05-2448. Clin Cancer Res. 2006. PMID: 16638868 Free article.

7

Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain.

Borsi L, Balza E, Leprini A, Ponassi M, Zardi L. Borsi L, et al. Among authors: balza e. Anal Biochem. 1991 Feb 1;192(2):372-9. doi: 10.1016/0003-2697(91)90551-4. Anal Biochem. 1991. PMID: 2035837

8

Increased plasma fibronectin concentrations in tumor bearing mice.

Siri A, Carnemolla B, Castellani P, Balza E, Raffanti S, Zardi L. Siri A, et al. Among authors: balza e. Cancer Lett. 1983 Dec;21(2):117-23. doi: 10.1016/0304-3835(83)90197-0. Cancer Lett. 1983. PMID: 6652617

9

Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin.

Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L. Balza E, et al. FEBS Lett. 1993 Oct 11;332(1-2):39-43. doi: 10.1016/0014-5793(93)80479-e. FEBS Lett. 1993. PMID: 7691659 Free article.

10

A high-affinity human antibody that targets tumoral blood vessels.

Tarli L, Balza E, Viti F, Borsi L, Castellani P, Berndorff D, Dinkelborg L, Neri D, Zardi L. Tarli L, et al. Among authors: balza e. Blood. 1999 Jul 1;94(1):192-8. Blood. 1999. PMID: 10381513 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters